Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 USD | -0.55% | +0.04% | +12.09% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Financials (USD)
Sales 2024 * | 170M | Sales 2025 * | 182M | Capitalization | 372M |
---|---|---|---|---|---|
Net income 2024 * | -2M | Net income 2025 * | 6M | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-166
x | P/E ratio 2025 * |
61.5
x | Employees | 357 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.4% |
Latest transcript on Anika Therapeutics, Inc.
1 day | -0.55% | ||
1 week | +0.04% | ||
Current month | +4.61% | ||
1 month | +2.54% | ||
3 months | +12.19% | ||
6 months | +34.53% | ||
Current year | +12.09% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 18-08-30 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 20-08-09 |
Anne Nunes
COO | Chief Operating Officer | 55 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 18-10-22 |
Sheryl Conley
BRD | Director/Board Member | 63 | 21-10-27 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 18-08-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 26 M€ | +0.78% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 25.4 | -0.55% | 83,692 |
24-03-27 | 25.54 | +0.71% | 57,868 |
24-03-26 | 25.36 | +1.08% | 55,020 |
24-03-25 | 25.09 | -1.45% | 141,102 |
24-03-22 | 25.46 | +0.28% | 83,961 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.09% | 372M | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |